In the last trading session, 1.05 million Candel Therapeutics Inc (NASDAQ:CADL) shares changed hands as the company’s beta touched -0.89. With the company’s per share
Candel Therapeutics Inc (NASDAQ:CADL) has a beta value of -0.91 and has seen 1.09 million shares traded in the last trading session. The company, currently
Candel Therapeutics Inc (NASDAQ:CADL)’s traded shares stood at 0.62 million during the last session, with the company’s beta value hitting -0.90. At the close of
In the last trading session, 1.03 million Candel Therapeutics Inc (NASDAQ:CADL) shares changed hands as the company’s beta touched -0.91. With the company’s per share
Candel Therapeutics Inc (NASDAQ:CADL)’s traded shares stood at 0.72 million during the last session, with the company’s beta value hitting -0.88. At the close of
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne